The Novo Nordisk Foundation has granted DKK 5.5 billion (€736 million) to the BioInnovation Institute (BII) to support life sciences and scientific innovation in Denmark and Europe. The funding will enable BII to expand its activities into new strategic areas and geographies, supporting even more entrepreneurs and start-up-companies. … Read More
Biotech company Pila Pharma has raised 20 million Swedish kronor ($2.08 million) in an almost fully covered capital raise, which includes a stock option for future use. Pila Pharma was founded by Danish researcher Dorte Gram, a former researcher at Novo Nordisk and was the first researcher to screen… Read More
Danish start-up InProTher has raised €6 million seed funding from private investors, with participation from the European Innovation Council (EIC) Fund. The financing will enable InProTher to advance its lead drug candidate, IPT001, a first-in-class immunotherapy against solid tumours, into clinical development. Incubated at… Read More
A science-centric network for women in senior positions across industry and academia has launched in Denmark to strengthen the life sciences industry and promote talent, diversity and inclusiveness. Women in Life Science Denmark (WiLD) has received support from the Novo Nordisk Foundation, contributing €56,000 ($60,293) over the… Read More
